Morning or evening administration of nasal calcitonin? Effects on biochemical markers of bone turnover
- 1 January 1997
- Vol. 20 (1) , 63-67
- https://doi.org/10.1016/s8756-3282(96)00307-9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorptionJournal of Clinical Endocrinology & Metabolism, 1995
- Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessmentJournal of Clinical Endocrinology & Metabolism, 1995
- Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone diseaseJournal of Clinical Endocrinology & Metabolism, 1994
- The effect of calcium supplementation on the circadian rhythm of bone resorptionJournal of Clinical Endocrinology & Metabolism, 1994
- Effects of continuous and cyclic nasal calcitonin administration in ovariectomized womenMaturitas, 1992
- Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageingClinical Science, 1992
- Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosisJournal of Clinical Endocrinology & Metabolism, 1992
- Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.Journal of Clinical Investigation, 1988
- Treatment of severe hypecalcaemia with calcitoninMetabolic Bone Disease and Related Research, 1980
- Treatment of Paget's Disease of Bone with Synthetic Salmon CalcitoninBMJ, 1974